• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-(2S, 4R)-4-氟谷氨酰胺PET成像在临床前肿瘤模型中的可重复性和再现性

Reproducibility and repeatability of 18F-(2S, 4R)-4-fluoroglutamine PET imaging in preclinical oncology models.

作者信息

Ayers Gregory D, Cohen Allison S, Bae Seong-Woo, Wen Xiaoxia, Pollard Alyssa, Sharma Shilpa, Claus Trey, Payne Adria, Geng Ling, Zhao Ping, Tantawy Mohammed Noor, Gammon Seth T, Manning H Charles

机构信息

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, United States of America.

Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, United States of America.

出版信息

PLoS One. 2025 Jan 9;20(1):e0313123. doi: 10.1371/journal.pone.0313123. eCollection 2025.

DOI:10.1371/journal.pone.0313123
PMID:39787098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11717184/
Abstract

INTRODUCTION

Measurement of repeatability and reproducibility (R&R) is necessary to realize the full potential of positron emission tomography (PET). Several studies have evaluated the reproducibility of PET using 18F-FDG, the most common PET tracer used in oncology, but similar studies using other PET tracers are scarce. Even fewer assess agreement and R&R with statistical methods designed explicitly for the task. 18F-(2S, 4R)-4-fluoro-glutamine (18F-Gln) is a PET tracer designed for imaging glutamine uptake and metabolism. This study illustrates high reproducibility and repeatability with 18F-Gln for in vivo research.

METHODS

Twenty mice bearing colorectal cancer cell line xenografts were injected with ~9 MBq of 18F-Gln and imaged in an Inveon microPET. Three individuals analyzed the tumor uptake of 18F-Gln using the same set of images, the same image analysis software, and the same analysis method. Scans were randomly re-ordered for a second repeatability measurement 6 months later. Statistical analyses were performed using the methods of Bland and Altman (B&A), Gauge Reproducibility and Repeatability (Gauge R&R), and Lin's Concordance Correlation Coefficient. A comprehensive equivalency test, designed to reject a null hypothesis of non-equivalence, was also conducted.

RESULTS

In a two-way random effects Gauge R&R model, variance among mice and their measurement variance were 0.5717 and 0.024. Reproducibility and repeatability accounted for 31% and 69% of the total measurement error, respectively. B&A repeatability coefficients for analysts 1, 2, and 3 were 0.16, 0.35, and 0.49. One-half B&A agreement limits between analysts 1 and 2, 1 and 3, and 2 and 3 were 0.27, 0.47, and 0.47, respectively. The mean square deviation and total deviation index were lowest for analysts 1 and 2, while coverage probabilities and coefficients of the individual agreement were highest. Finally, the definitive agreement inference hypothesis test for equivalency demonstrated that all three confidence intervals for the average difference of means from repeated measures lie within our a priori limits of equivalence (i.e. ± 0.5%ID/g).

CONCLUSIONS

Our data indicate high individual analyst and laboratory-level reproducibility and repeatability. The assessment of R&R using the appropriate methods is critical and should be adopted by the broader imaging community.

摘要

引言

测量重复性和再现性(R&R)对于充分发挥正电子发射断层扫描(PET)的潜力至关重要。多项研究评估了使用18F-FDG(肿瘤学中最常用的PET示踪剂)的PET的再现性,但使用其他PET示踪剂的类似研究却很少。更少的研究使用专门为此任务设计的统计方法来评估一致性和R&R。18F-(2S,4R)-4-氟谷氨酰胺(18F-Gln)是一种用于成像谷氨酰胺摄取和代谢的PET示踪剂。本研究表明18F-Gln在体内研究中具有高再现性和重复性。

方法

给20只携带结直肠癌细胞系异种移植瘤的小鼠注射约9 MBq的18F-Gln,并在Inveon微型PET中成像。三名研究人员使用同一组图像、相同的图像分析软件和相同的分析方法分析18F-Gln的肿瘤摄取情况。6个月后对扫描结果进行随机重新排序以进行第二次重复性测量。使用布兰德-奥特曼(B&A)方法、量具再现性和重复性(量具R&R)以及林氏一致性相关系数进行统计分析。还进行了一项旨在拒绝非等效性零假设的综合等效性检验。

结果

在双向随机效应量具R&R模型中,小鼠之间的方差及其测量方差分别为0.5717和0.024。再现性和重复性分别占总测量误差的31%和69%。研究人员1、2和3的B&A重复性系数分别为0.16、0.35和0.49。研究人员1与2、1与3以及2与3之间的B&A一致性界限的一半分别为0.27、0.47和0.47。研究人员1和2的均方差和总偏差指数最低,而个体一致性的覆盖概率和系数最高。最后,等效性的确定性一致性推断假设检验表明,重复测量均值差异的所有三个置信区间均在我们预先设定的等效性界限内(即±0.5%ID/g)。

结论

我们的数据表明个体研究人员和实验室水平具有高再现性和重复性。使用适当方法评估R&R至关重要,更广泛的成像领域应采用这种方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89aa/11717184/44060edf16f6/pone.0313123.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89aa/11717184/3db09276426e/pone.0313123.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89aa/11717184/1b61588fada0/pone.0313123.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89aa/11717184/44060edf16f6/pone.0313123.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89aa/11717184/3db09276426e/pone.0313123.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89aa/11717184/1b61588fada0/pone.0313123.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89aa/11717184/44060edf16f6/pone.0313123.g003.jpg

相似文献

1
Reproducibility and repeatability of 18F-(2S, 4R)-4-fluoroglutamine PET imaging in preclinical oncology models.18F-(2S, 4R)-4-氟谷氨酰胺PET成像在临床前肿瘤模型中的可重复性和再现性
PLoS One. 2025 Jan 9;20(1):e0313123. doi: 10.1371/journal.pone.0313123. eCollection 2025.
2
Alanine and glycine conjugates of (2S,4R)-4-[F]fluoroglutamine for tumor imaging.(2S,4R)-4-[F]氟谷氨酸的丙氨酸和甘氨酸缀合物用于肿瘤成像。
Nucl Med Biol. 2018 May;60:19-28. doi: 10.1016/j.nucmedbio.2018.02.001. Epub 2018 Feb 13.
3
PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.正电子发射断层扫描(PET)成像通过 18F-(2S,4R)4-氟谷氨酸探测肿瘤中的谷氨酰胺分解代谢。
J Nucl Med. 2011 Dec;52(12):1947-55. doi: 10.2967/jnumed.111.093815. Epub 2011 Nov 15.
4
Kinetic Modeling of F-(24)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism.乳腺癌小鼠模型中 F-(24)4-氟谷氨酸的动力学建模,以评估谷氨酰胺池大小作为肿瘤谷氨酰胺代谢的指标。
J Nucl Med. 2021 Aug 1;62(8):1154-1162. doi: 10.2967/jnumed.120.250977. Epub 2020 Dec 4.
5
(2S,4R)-4-[F]Fluoroglutamine as a PET Indicator for Bone Marrow Metabolism Dysfunctional: from Animal Experiments to Clinical Application.(2S,4R)-4-[F]氟谷氨酸作为骨髓代谢功能障碍的 PET 指示剂:从动物实验到临床应用。
Mol Imaging Biol. 2019 Oct;21(5):945-953. doi: 10.1007/s11307-019-01319-4.
6
Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer.4-[18F]氟谷氨酰胺PET用于评估肺癌中ASCT2表达的临床前评估
Mol Imaging Biol. 2016 Feb;18(1):18-23. doi: 10.1007/s11307-015-0862-4.
7
Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents.18F 标记谷氨酸和谷氨酰胺作为肿瘤代谢显像剂的比较评价。
J Nucl Med. 2012 Oct;53(10):1616-24. doi: 10.2967/jnumed.111.101279. Epub 2012 Aug 30.
8
Reproducibility of functional volume and activity concentration in 18F-FDG PET/CT of liver metastases in colorectal cancer.结直肠癌肝转移 18F-FDG PET/CT 中功能体积和活性浓度的可重复性。
Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1858-67. doi: 10.1007/s00259-012-2233-6. Epub 2012 Sep 4.
9
Evaluation of (2S,4S)-4-[F]FEBGln as a Positron Emission Tomography Tracer for Tumor Imaging.评估(2S,4S)-4-[F]FEBGln 作为肿瘤成像正电子发射断层扫描示踪剂的价值。
Mol Pharm. 2023 Oct 2;20(10):5195-5205. doi: 10.1021/acs.molpharmaceut.3c00544. Epub 2023 Aug 30.
10
In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of F-(2S,4R)-4-Fluoroglutamine.体内正电子发射断层扫描(PET)检测肿瘤谷氨酰胺流量和代谢:F-(2S,4R)-4-氟谷氨酸在人体试验中的应用。
Radiology. 2018 May;287(2):667-675. doi: 10.1148/radiol.2017162610. Epub 2018 Jan 31.

本文引用的文献

1
Robustness of radiomic features in magnetic resonance imaging for patients with glioblastoma: Multi-center study.胶质母细胞瘤患者磁共振成像中影像组学特征的稳健性:多中心研究。
Phys Imaging Radiat Oncol. 2022 May 14;22:131-136. doi: 10.1016/j.phro.2022.05.006. eCollection 2022 Apr.
2
[F](2,4)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma.[F](2,4)-4-氟谷氨酰胺作为骨髓瘤中的一种新型正电子发射断层显像剂
Front Oncol. 2021 Oct 12;11:760732. doi: 10.3389/fonc.2021.760732. eCollection 2021.
3
Kinetic Modeling of F-(24)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism.
乳腺癌小鼠模型中 F-(24)4-氟谷氨酸的动力学建模,以评估谷氨酰胺池大小作为肿瘤谷氨酰胺代谢的指标。
J Nucl Med. 2021 Aug 1;62(8):1154-1162. doi: 10.2967/jnumed.120.250977. Epub 2020 Dec 4.
4
Using multiple agreement methods for continuous repeated measures data: a tutorial for practitioners.使用多种一致性方法分析连续重复测量资料:一份面向实践者的教程。
BMC Med Res Methodol. 2020 Jun 12;20(1):154. doi: 10.1186/s12874-020-01022-x.
5
Target the human Alanine/Serine/Cysteine Transporter 2(ASCT2): Achievement and Future for Novel Cancer Therapy.靶向人丙氨酸/丝氨酸/半胱氨酸转运蛋白 2(ASCT2):新型癌症治疗的成就与未来。
Pharmacol Res. 2020 Aug;158:104844. doi: 10.1016/j.phrs.2020.104844. Epub 2020 May 11.
6
Dynamic PET/CT imaging of F-(2S, 4R)4-fluoroglutamine in healthy volunteers and oncological patients.健康志愿者和肿瘤患者中F-(2S, 4R)4-氟谷氨酰胺的动态PET/CT成像
Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2280-2292. doi: 10.1007/s00259-019-04543-w. Epub 2020 Mar 12.
7
(2S, 4R)-4-[F]Fluoroglutamine for In vivo PET Imaging of Glioma Xenografts in Mice: an Evaluation of Multiple Pharmacokinetic Models.(2S, 4R)-4-[F]氟谷氨酸用于小鼠胶质瘤异种移植体的体内 PET 成像:多种药代动力学模型的评估。
Mol Imaging Biol. 2020 Aug;22(4):969-978. doi: 10.1007/s11307-020-01472-1.
8
Preclinical PERCIST and 25% of SUV Threshold: Precision Imaging of Response to Therapy in Co-clinical F-FDG PET Imaging of Triple-Negative Breast Cancer Patient-Derived Tumor Xenografts.临床前 PERCIST 和 25% SUV 阈值:三阴性乳腺癌患者来源肿瘤异种移植的 F-FDG PET 成像中联合临床 25% SUV 阈值对治疗反应的精准成像。
J Nucl Med. 2020 Jun;61(6):842-849. doi: 10.2967/jnumed.119.234286. Epub 2019 Nov 22.
9
Pharmacokinetic Assessment of F-(24)-4-Fluoroglutamine in Patients with Cancer.癌症患者 F-(24)-4-氟谷氨酸的药代动力学评估。
J Nucl Med. 2020 Mar;61(3):357-366. doi: 10.2967/jnumed.119.229740. Epub 2019 Oct 10.
10
Standardization of Preclinical PET/CT Imaging to Improve Quantitative Accuracy, Precision, and Reproducibility: A Multicenter Study.临床前 PET/CT 成像标准化以提高定量准确性、精密度和可重复性:一项多中心研究。
J Nucl Med. 2020 Mar;61(3):461-468. doi: 10.2967/jnumed.119.231308. Epub 2019 Sep 27.